REQUEST A DEMO
Total
USD $0.00
Search more companies

Novo Nordisk Pharma EAD (Ново Нордиск Фарма ЕАД) (Bulgaria)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Novo Nordisk Pharma EAD Profile Updated: September 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Novo Nordisk Pharma EAD (Ново Нордиск Фарма ЕАД) is based in Bulgaria, with the head office in Sofia. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. Novo Nordisk Pharma EAD (Ново Нордиск Фарма ЕАД) was incorporated on April 15, 2005. It currently has a total number of 170 (2024) employees. From the latest financial highlights, Novo Nordisk Pharma EAD (Ново Нордиск Фарма ЕАД) reported a net sales revenue increase of 20.3% in 2024. There was a total growth of 48.19% in Novo Nordisk Pharma EAD (Ново Нордиск Фарма ЕАД)’s total assets over the same period. In 2024, Novo Nordisk Pharma EAD (Ново Нордиск Фарма ЕАД)’s net profit margin increased by 0.1%.

Headquarters
Cherni Vrah 51, Bl. Biznes Gardan, Ofis H, Sgrada 3, ET. 4
Sofia; Sofia - city; Postal Code: 1407

Contact Details: Purchase the Novo Nordisk Pharma EAD (Ново Нордиск Фарма ЕАД) report to view the information.

Website: http://www.novonordisk.bg/

Basic Information
Total Employees:
Purchase the Novo Nordisk Pharma EAD (Ново Нордиск Фарма ЕАД) report to view the information.
Outstanding Shares:
Purchase the Novo Nordisk Pharma EAD (Ново Нордиск Фарма ЕАД) report to view the information.
Registered Capital:
Purchase the Novo Nordisk Pharma EAD (Ново Нордиск Фарма ЕАД) report to view the information.
Financial Auditors:
Purchase the Novo Nordisk Pharma EAD (Ново Нордиск Фарма ЕАД) report to view the information.
Incorporation Date:
April 15, 2005
Key Executives
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Novo Nordisk Pharma EAD (Ново Нордиск Фарма ЕАД) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
20.3%
Total Operating Revenue
24.14%
Operating Profit
123.3%
EBITDA
129.39%
Net Profit/Loss for the Period
23.75%
Total Assets
48.19%
Total Equity
-8.27%
Operating Profit Margin
3.22%
Net Profit Margin
0.1%
Return on Equity (ROE)
8.22%
Debt / Equity
37.61%
Quick Ratio
0.26%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?